Verition Fund Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

  • $23.6 Billion
  • Q4 2024

A detailed history of Verition Fund Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 26,311 shares of REGN stock, worth $16.7 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
26,311
Previous 1,054 2396.3%
Holding current value
$16.7 Million
Previous $1.11 Million 1591.52%
% of portfolio
0.08%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$701.85 - $1046.91 $17.7 Million - $26.4 Million
25,257 Added 2396.3%
26,311 $18.7 Million
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $7.68 Million - $9.01 Million
-7,499 Reduced 87.68%
1,054 $1.11 Million
Q2 2024

Aug 14, 2024
SELL
$883.2 - $1071.19 $4.13 Million - $5.01 Million
-4,679 Reduced 35.36%
8,553 $8.99 Million
Q1 2024

May 14, 2024
BUY
$902.69 - $993.35 $7.63 Million - $8.39 Million
8,451 Added 176.76%
13,232 $12.7 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $3.71 Million - $4.22 Million
4,781 New
4,781 $4.2 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $23,801 - $28,231
34 Added 4.65%
765 $549,000
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $8.81 Million - $10.7 Million
-12,941 Reduced 94.65%
731 $600,000
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $9.17 Million - $9.95 Million
12,986 Added 1893.0%
13,672 $9.86 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $685,320 - $864,838
-1,194 Reduced 63.51%
686 $473,000
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $724,918 - $976,746
1,322 Added 236.92%
1,880 $1.11 Million
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $276,730 - $324,769
-465 Reduced 45.45%
558 $390,000
Q4 2021

May 03, 2022
SELL
$543.48 - $670.97 $4.24 Million - $5.23 Million
-7,800 Reduced 88.41%
1,023 $646,000
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $3.99 Million - $4.93 Million
7,341 Added 495.34%
8,823 $5.57 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $447,169 - $530,467
-779 Reduced 34.45%
1,482 $897,000
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $1.07 Million - $1.26 Million
2,261 New
2,261 $1.26 Million
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $361,116 - $459,024
-755 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$544.75 - $658.21 $78,444 - $94,782
-144 Reduced 16.02%
755 $423,000
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $443,494 - $578,884
899 New
899 $561,000
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $1.19 Million - $1.74 Million
-3,528 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $2.58 Million - $3.54 Million
-9,403 Reduced 72.72%
3,528 $1.33 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $666,422 - $775,916
2,437 Added 23.22%
12,931 $3.59 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $2.85 Million - $3.95 Million
9,519 Added 976.31%
10,494 $3.29 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $362,778 - $428,580
975 New
975 $400,000
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $1.24 Million - $1.48 Million
-3,682 Closed
0 $0
Q3 2018

Nov 15, 2018
BUY
$351.14 - $408.51 $1.29 Million - $1.5 Million
3,682 New
3,682 $1.49 Million
Q1 2018

May 16, 2018
SELL
$315.82 - $393.78 $579,529 - $722,586
-1,835 Closed
0 $0
Q4 2017

Feb 15, 2018
SELL
$358.63 - $469.95 $31,559 - $41,355
-88 Reduced 4.58%
1,835 $690,000
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $829,543 - $969,192
1,923
1,923 $860,000

Others Institutions Holding REGN

# of Institutions
1,497
Shares Held
86.6M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $68B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email